Patent news would be nice. Orphan drug to be applied in late of this year. After FDA approval for human trials I presume. Too early or not I filled today for my short term. What happens with the financing trip will determine long term. Feel like we could get a push to mid-high teens which I'm starting to think might be my let go and let the dust settle price. Is there something in August that I'm not thinking of right now? Keeps sticking out in my head as a possible key time.
Thoughts always welcome.
(2)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links